Clinical trials
Phase 3 Epilepsies, Partial trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
64 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 2 |
| 2002 | 3 |
| 2003 | 1 |
| 2004 | 9 |
| 2005 | 2 |
| 2006 | 8 |
| 2007 | 4 |
| 2008 | 7 |
| 2009 | 3 |
| 2011 | 2 |
| 2012 | 1 |
| 2013 | 2 |
| 2014 | 1 |
| 2015 | 1 |
| 2016 | 1 |
| 2017 | 1 |
| 2021 | 1 |
| 2022 | 1 |
| 2023 | 1 |
| 2026 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 51 |
| Terminated | 7 |
| Recruiting | 3 |
| Active, not recruiting | 1 |
| Enrolling by invitation | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 8 |
| Pfizer | 7 |
| SK Life Science, Inc. | 7 |
| Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 6 |
| UCB Pharma | 6 |
| Bial - Portela C S.A. | 4 |
| GlaxoSmithKline | 4 |
| UCB BIOSCIENCES, Inc. | 3 |
| Marinus Pharmaceuticals | 2 |
| Rapport Therapeutics Inc. | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Epilepsies, Partial | 64 |
| Epilepsy | 39 |
| Seizures | 33 |
| Epilepsy, Complex Partial | 8 |
| Epilepsy, Generalized | 3 |
| Epilepsy, Partial, Motor | 2 |
| Brain Diseases | 1 |
| Epilepsy, Tonic-Clonic | 1 |
| Sleep Deprivation | 1 |
| Weight Loss | 1 |
Trials
Showing 26 to 50 of 64. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.